Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Acta Biochimica Polonica|April 30, 2017
Aliskiren reduces albuminuria after kidney transplantationLeszek Tylicki, Alicja M Debska-Slizien, Slawomir Lizakowski, et al.
Medicina (Kaunas, Lithuania)|August 6, 2021
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH ProjectKarolina Polewska, Piotr Tylicki, Bogdan Biedunkiewicz, et al.
Transplantation Proceedings|March 29, 2022
Short-term Effects of Losartan on Cardiovascular Risk and Allograft Injury Biomarkers in Kidney Transplant RecipientsIzabella Kuźmiuk-Glembin, Zbigniew Heleniak, Renata Pięta, et al.
Medicina (Kaunas, Lithuania)|June 21, 2020
Tumor Suppressors-HTRA Proteases and Interleukin-12-in Pediatric Asthma and Allergic Rhinitis PatientsJoanna Renke, Eliza Wasilewska, Sabina Kędzierska-Mieszkowska, et al.
Acta Biochimica Polonica|August 28, 2018
Immune response against HtrA proteases in children with cutaneous mastocytosisJoanna Renke, Sabina Kędzierska-Mieszkowska, Magdalena Lange, et al.
Frontiers in Psychiatry|August 7, 2024
Screening for depression in chronic haemodialysis patients as a part of care in dialysis setting: a cross-sectional studyAlicja Kubanek, Marcin Renke, Beata R Godlewska, et al.
Advances in Medical Sciences|August 9, 2014
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over studyMarcin Renke, Sławomir Lizakowski, Leszek Tylicki, et al.
Transplantation Proceedings|May 24, 2020
Pregnancy After Kidney Transplantation With Maternal and Pediatric Outcomes: A Single-Center ExperienceAlicja Dębska-Ślizień, Joanna Gałgowska, Barbara Bułło-Piontecka, et al.
Frontiers in Immunology|August 8, 2022
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 VaccineMagdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, et al.
Vaccines|April 23, 2022
Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in PolandPiotr Rzymski, Monika Pazgan-Simon, Juliusz Kamerys, et al.
Pageof 7